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Abstract 
Cholinergic modulation of spontaneous GABAergic currents (mIPSC) was studied using whole-cell patch methods in mouse accessory olfactory 
bulb slices. Carbachol (above 100 !M) administration produced an increase in the mIPSC frequency in mitral cells, but did not affect the 
responses of mitral cells to GABA. The carbachol effect persisted in the presence of combined ionotropic and metabotropic glutamatergic 
receptor antagonists. The carbachol effect was reduced by the muscarinic receptor type-1 and -4 (M1, M4) antagonist pirenzepine (10 !M), but 
not by the M2 and M4 antagonist himbacine (10 !M). The KCNQ/Kv7 potassium channel openers retigabine (80 !M) and diclofenac (300 !M) 
blocked the carbachol action, while the KCNQ potassium channel blocker XE-911 (20 !M) increased the mIPSC frequency. XE-911’s action 
persisted in the presence of glutamate receptor blockers. In the presence of carbachol, mIPSCs were abolished by Ni (200 !M), while being 
insensitive to the calcium channel blocker nimodipine (30 !M), suggesting a role for R-type calcium channels in the GABA release. These 
results suggest that carbachol closed KCNQ channels by stimulating M1 receptors on granule cell dendrites, and the resulting depolarized and 
unstable membrane promoted calcium influx, thus increasing the GABA release. The possible role of acetylcholine in facilitating formation of a 
pheromone memory in mice is also discussed. 
 
Classification Terms 
Section: Neurophysiology 
Key words: M-current, Pheromone, mIPSC, Mitral cell, Granule cell 
  
Abbreviations 
AC, adenylate cyclase; ACh, acetylcholine; AOB, accessory olfactory bulb; AP3, DL-2-amino-3-phosphonopropionic acid; BAPTA, 
1,2-bis-(2-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid; CNQX, 6-cyano-7-nitroquinoxaline-2,3-dione; D-AP5, 
D-2-amino-5-phosphonovaleric acid; CNS, central nervous system; 4-DAMP, 4-diphenylacetoxy-N-methylpiperidine methiodide; DMSO, 
dimethyl sulfoxide; IP3, inositol 1,4,5-trisphosphate; K-S test, Kolmogorov-Smirnov test; mIPSC, miniature inhibitory post-synaptic current; PLC, 
phospholipase C; MCPG, (RS)-!-methyl-4-carboxyphenylglycine; OB, olfactory bulb; TEA, tetra-ethyl ammonium; TTX, tetrodotoxin 
 
 
Introduction 
The accessory olfactory bulb (AOB) is the first central nervous system 
(CNS) relay for processing pheromonal sensory information (Luo et al., 
2003). Although AOB is not present in humans (Meisami et al., 1998), it is 
an attractive region for study because of its simple structure, consisting of 
only three types of neurones (Mori, 1987) and its implicated functions such 
as information integration (Xu et al., 2005; Hendrickson et al., 2008) or 
memory storage (Kaba et al., 1994; Matsuoka et al., 2004; Binns and 
Brennan, 2005). 
The mitral cell, the relay and output neurone in the AOB, has 
several long dendrites that receive sensory input. Along the length of the 
dendrites, numerous dendrodendritic reciprocal synapses are made with the 
dendrites of interneurones (granule cells). Glutamate is released from the 
mitral cell, while GABA is released from the granule cell (Jia et al., 1999; 
Taniguchi and Kaba, 2001). Spontaneous release of GABA from granule 
cells can be recorded as chloride currents in mitral cells using whole-cell 
recording; neuromodulators can increase the spontaneous mIPSC frequency 
via stimulation of noradrenergic !1 receptors (Araneda and Firestein, 2006) 
or mGluR1 metabotropic glutamate receptors (Castro et al., 2007). 
The neuromodulator acetylcholine (ACh) has been 
implicated in attention and memory formation (Furey et al., 2000). 
Anatomical studies in rodents suggest that cholinergic centrifugal fibres 
terminate in the AOB (Carson and Burd, 1980; Macrides et al., 1981). 
These most likely originate from basal forebrain magnocellular neurones in 
the nucleus of the horizontal limb of the diagonal band (HDB; Macrides et 
al., 1981) or hypothalamic neurones in the bed nucleus of stria terminalis 
(BNST; de Olmos et al., 1978). These two regions are in close proximity. 
Further, intrinsic cholinergic neurones, though rare, are found in the granule 
cell layer (Ojima et al., 1988) of the AOB. Muscarinic receptor mRNAs are 
expressed in the AOB (strong M1 and M4; weak M3: Buckley et al., 1988). 
Confirmed actions of ACh in the AOB, however, have not been 
demonstrated. Though cholinergic action increases spontaneous mIPSCs in 
the olfactory bulb (Castillo et al., 1999; Ghatpande et al., 2006), this has not 
been shown in the AOB. As the effects of some cholinergic receptors are 
linked to the phospholipase C (PLC) pathway via the Gq11G-protein (see 
Caulfield and Birdsall, 1998 for review), we hypothesized that cholinergic 
stimulation has actions on mIPSCs similar to mGluR1 and noradrenergic !1 
receptors stimulations that are also linked to Gq11G-protein. The current 
work tests this hypothesis and examines the mechanisms that underlie 
increases in spontaneous mIPSC frequency occurring via cholinergic 
stimulation in the AOB.  
 
 
Results 
Carbachol administration increased the frequency of 
spontaneous mIPSCs in mitral cells 
Spontaneous inward currents (ranging from 0 to 3 Hz in frequency, mean of 
cells employed for analysis, n = 30, 0.8 ± 0.8 [SD] Hz) were observed in 
whole-cell recordings made from mitral cells. Cells with a very low 
frequency of spontaneous currents (fewer than one per 30 s) were not 
included in the analysis. When the holding potential was changed from –70 
mV to +30 mV, the current reversed polarity around 0 mV, which is the 
 2 
chloride equilibrium potential under the following recording conditions: 
extracellular Cl: 137 mM, intracellular Cl: 162 mM, 58log(137/162) = -4.39 
mV (Fig. 1A). Bicuculline methiodide (20 !M), a GABAA receptor blocker, 
nearly abolished the spontaneous currents (n = 4, Fig. 1B) completely. 
These findings suggest that the spontaneous currents are mediated by the 
opening of GABAA chloride channels. Thus, they are the so-called mIPSCs 
(GABA mediated currents recorded in the presence of TTX, though they 
were not miniature; see below).   
Carbachol (200 !M) application produced a marked increase in 
spontaneous mIPSC frequency. Eleven out of 21 cells had at least one time 
window (see Experimental procedures) with significant frequency increase 
by Kolmogorov-Smirnov test of inter-event interval cumulative plots (Fig. 
1Ca, c). However in some carbachol applied cells (6 out of 21 cells), the 
frequency did not show any increase or even showed a run down (compared 
with 7 out of 9 cells in control vehicle applied cells). Bicuculline abolished 
the spontaneous currents (10 out of 10 cells), suggesting that the 
spontaneous currents increasing in frequency were also GABAergic and 
were not contaminated by others such as glutamatergic currents. The extent 
of increase and the latency of response varied among cells (Fig.1Ca). The 
responding cells tended to show long-lasting responses. Without any drug 
application, the mIPSC frequency tended to increase gradually in the first 5 
min after the recording patch formation and run down slowly thereafter (Fig. 
1Cb). To avoid this run-down, the carbachol applications and the data 
collection for analysis were done in the most stable phase, which occurred 
between 10 and 30 min after the patch formation.  
 The average baseline current frequency of recorded cells before 
any drug application was 0.74 ± 0.69 Hz in the carbachol-applied group, 
and 1.04 ± 0.95 Hz in the vehicle applied control group; these were not 
significantly different (two tailed t-test P = 0.23). The average current 
frequencies following carbachol or vehicle application were (in Hz ± SD): 
carbachol group 0.67 ± 0.70 (0-3 min after), 1.00 ± 1.07 (3-6 min), 1.07 
±1.35 (6-9 min); control group 0.70 ± 0.74 (0-3 min), 0.57 ± 0.56 (3-6 min), 
0.48 ± 0.48 (6-9 min).  
The distribution of current frequency change values was skewed 
with a subgroup of non-responsive cells and was not Gaussian (skewness, 
2.54, Fig. 1D). Therefore, the nonparametric Mann-Whitney U-test was 
used to detect significance (see Experimental procedures). This method for 
analysis demonstrated that carbachol (200 !M) significantly increased the 
mIPSC frequency compared with vehicle application (carbachol, n = 21, 
control, n = 9; frequencies increased by 0.4 ! 1.1 vs. -0.5 ! 0.5 Hz, P < 
0.0001, U-test; Fig 1E). The 200 !M concentration seemed not to saturate 
the carbachol action because a higher concentration (up to 1 mM) in later 
experiments resulted in fewer unresponsive cells and reduced latencies (9 
out of 11 cells with 1mM application had at least one time window with a 
significant increase in frequency).  
Though rarely, gigantic currents were observed (Fig 1F). Less 
than 3% of currents in any recording were giant currents with both 
amplitude larger than 100 pA and width greater than 500 ms. The giants 
appeared independently of carbachol applications (carbachol n = 21, 0.6 ± 
0.8 (SD) % of the total events; control n = 9, 1.1 ± 1.5 (SD) %: t-test p = 
0.39). They were probably caused by synchronous GABA release, but this 
could not be tested because their generations were rare and unpredicted. 
 
Carbachol also increased the current amplitudes in some cells  
The mean current amplitude in each base time window was 108 ± 46 pA in 
the carbachol group (n = 21), and 98 ± 22 pA in the control group (n = 9), 
and these values were not significantly different (P = 0.48, t-test). The 
current amplitude change ratios (amplitude mean value in any time 
windows/amplitude mean value in base time window) were: carbachol 
group (n = 21), 1.6 ± 2.6 (0-3 min), 1.6 ± 2.6 (3-6 min), 1.7 ± 3.0 (6-9 min); 
control group (n = 9), 1.1 ± 0.3 (0-3 min), 0.9 ± 0.2 (3-6 min), 1.0 ± 0.2 
(6-9 min). Though large amplitude increases were occasionally seen (Fig. 
2A), t-tests did not show any significant differences (carbachol n = 21, 
control n = 9; 0-3 min, P = 0.32; 3-6 min, P = 0.30; 6-9 min, P = 0.26). 
Also U-tests, by pooling the amplitude change ratios in each group as in the 
frequency analysis, did not show any significance (carbachol, n = 21, 
control, n = 9; amplitude change ratios 1.6 ! 2.7 vs. 1 ! 0.2, P = 0.60, 
U-test). 
Cumulative plot analysis of mIPSC amplitudes was done on 
selected cells whose recordings were the most stable (carbachol application 
n = 10, control n = 6). Carbachol group cells were those with good (more 
than two time windows with increased current frequency compared with the 
base time window) response to carbachol. For each cell, four curves were 
plotted for the time windows of base, 0-3, 3-6, and 6-9 min. In each cell, 
curve shifts in respect to the base time window were diagnosed by the K-S 
test (P < 0.05, two tailed) as: leftward significant, rightward significant with 
P < 0.05, or no significant shift (leftward significant shift indicates a 
decrease in current amplitude while rightward significant shift indicates an 
increase in current amplitude). In the ten cells that had carbachol 
application, a total of 30 curves were assessed for a curve shift; 14 curves 
showed a leftward shift, 5 curves showed a rightward shift, 1 curve showed 
a crossing (Fig. 2B) with both significant left and right-ward shifts, and 10 
curves did not show any significant shift (Fig. 2B). In the 6 control cells, a 
total of 18 curves were assessed for the shift; 7 curves showed a leftward 
shift and the remaining 11 curves did not show a significant shift (Fig. 2B). 
Of interest is the observation that curves for both the carbachol and control 
cells showed a similar frequency of leftward shift, while the rightward shift 
was only observed in the carbachol-exposed cells (4 cells out of 10 
carbachol-exposed cells, one curve each from 3 cells and 2 curves from 1 
cell). The leftward shifts (decreases in mIPSC amplitude) were 
carbachol-independent, as they were observed in both carbachol and control 
cells with similar frequency (47% vs. 39%).  
We considered two mechanisms to explain the increase in 
current amplitude resulting from carbachol administration. The first 
mechanism considered was the selective action of carbachol on 
dendrodendritic synapses near the recording site resulting in increases in 
large currents that were not reduced in amplitude by electronic attenuation. 
This is possible because more cholinergic fibres are seen in the mitral cell 
body side than in the cell’s dendritic tip side (Carson and Burd, 1980). The 
second mechanism consists of a quantal increase in the GABA released 
affecting postsynaptic currents. This increase may be achieved by 
increasing synaptic vesicle content or by increasing the number of vesicles 
released for a mIPSC. Analysis of current shapes suggested that a single 
synapse could handle multiple levels of transmission (see below). It is also 
possible that greatly increased presynaptic calcium works on sites other 
than the known release triggers to increase the pool of readily releasable 
vesicles (Sakaba, 2008). However, frequency change value to amplitude 
change ratio plots did not show a correlation (Fig. 2C), suggesting 
amplitude and frequency changes are independent processes. Thus, 
amplitude changes are probably dependent on the current profiles of a 
subpopulation of granule cells that are activated by carbachol, but not 
dependent on presynaptic calcium availability. 
 
Carbachol administration did not change the sensitivity of 
mitral cells to GABA 
The rise in the amplitude of mIPSCs by carbachol administration posed the 
possibilities that carbachol either acted at presynaptic sites (on granule 
cells) to increase quantal GABA release, or at post synaptic sites (on mitral 
cells) to increase their sensitivity to the released GABA. To clarify this 
matter, we next tested whether or not carbachol application increased the 
response of mitral cell to puff-applied GABA (Fig. 3A). The amplitude 
increase ratios (see Methods) for the carbachol group (n = 7) were 1.08 ± 
0.17 (mean ± SD) at 0-3 min, 1.10 ± 0.25 at 3-6 min, and 1.16 ± 0.45 at 6-9 
min, whereas the ratios for the control group (n = 6) were 0.85 ± 0.34 at 0-3 
min, 1.09 ± 0.32 at 3-6 min, and 0.96 ± 0.71 at 6-9 min. No significant 
differences were seen in the ratios of any time windows between the 
carbachol and control groups (t-test: 0-3 min, P = 0.67; 3-6 min, P = 0.57; 
6-9 min, P = 0.81; Fig. 3B). Non-parametric analysis of the puff current 
amplitude, using the same method as the frequency analysis (replacing 
frequency change values with the amplitude change ratio values) also failed 
to show a significant rise by carbachol application compared with 
vehicle-only application (1 mM carbachol, n = 7, control, n = 6; amplitude 
change ratios 1.1 ! 0.3 vs. 1.0 ! 0.5, P = 0.37, U-test), while the 
background frequency (see Methods) of mIPSCs showed a significant 
increase in the carbachol group compared with the vehicle group (1 mM 
carbachol, n = 7, control, n = 6; frequencies increased by 2.4 ! 2.1 vs. 0.5 
! 0.6 Hz, P = 0.001, U-test). In some cells, increases in both the 
frequency and amplitude of mIPSCs were robust even without an increase 
in the amplitude of the GABA puff current (Fig. 3C). We can thus conclude 
that the influence of carbachol upon release sites on granule cells and not 
upon the sensitivity of mitral cells to GABA underlies the observed 
increases in spontaneous mIPSC frequency in mitral cells. 
 
The carbachol action was mediated by M1 receptors 
Scopolamine (100 !M), a muscarinic antagonist, blocked the action of 1 
mM carbachol (scopolamine, n = 7, control, n = 7; frequencies increased by 
-0.3 ! 0.6 vs. 0.5 ! 0.6 Hz, P = 0.001, U-test; Fig. 4A). Application of 
pilocarpine (300 !M), a muscarinic agonist, resulted in increases in the 
mIPSC frequency (pilocarpine, n = 4, control, n = 5; frequencies increased 
by 3.9 ! 3.5 vs. -0.1 ! 1.2 Hz, P = 0.0004, U-test; Fig. 4A). These 
results demonstrate the carbachol action to be muscarinic.  
We next tested which muscarinic receptor subtypes (M1~M5) 
were involved. Pirenzepine at 10 !M (an antagonist for M1 and M4) 
blocked the action of 100 !M carbachol (pirenzepine, n = 7, control, n = 6; 
frequencies increased by -0.4 ! 0.7 vs. 0.8 ! 1.5 Hz, P = 0.001, U-test; 
Fig. 4A).  
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Himbacine, an antagonist for M2 and M4 receptors, could not 
block the 100 !M carbachol action (himbacine 1 !M, n = 3, frequencies 
increased by 0.0 ± 1.0 Hz; 10 !M n = 1, 1.0 ± 0.5 Hz; Fig. 4B). The M3 
antagonist, 4-DAMP, also could not inhibit the 100 !M carbachol action 
(4-DAMP 30 nM, n = 2, frequencies increased by 1.1 ± 1.4 Hz; 300 nM, n 
= 2, 0.6 ± 0.9 Hz; Fig. 4B).  
The demonstrated sensitivity to pirenzepine suggests M1 or M4 
as likely candidates, while insensitivity to himbacine or 4-DAMP suggests 
M2, M3, and M4 as unlikely. Taken together, these response profiles to 
muscarinic antagonists suggest that the receptor subtype involved in the 
carbachol action was M1. 
 
Carbachol acted on granule cells and possibly also on mitral 
cells to increase the mIPSC frequency 
Two possibilities were considered to explain the mechanisms of carbachol’s 
actions upon the mIPSCs. The first possibility is that carbachol may act 
directly on cholinergic receptors on granule cells to increase GABA release. 
The second is that carbachol may act upon mitral cell receptors to increase 
glutamate release, which would then stimulate granule cell GABA release 
(Fig. 5A). The third is that both sites are involved (as in the olfactory bulb; 
Ghatpande et al., 2009). 
We tested the action of carbachol in the presence of 
glutamatergic blockers. Glutamatergic actions can be mediated by either 
ionotropic or metabotropic glutamate receptors. Among the metabotropic 
glutamate receptors, mGluR1 alone is responsible for increases in 
spontaneous GABA release from granule cells (Castro et al., 2007). Thus, 
we applied carbachol together in the presence of antagonists of ionotropic 
glutamate receptors (kynurenic acid, CNQX and D-AP5) and mGluR1 
receptors (AP3 and MCPG). Carbachol (1 mM) application, in the presence 
of kynurenic acid (5 mM) and AP3 (200 !M), still caused an trend of 
increase in the spontaneous mitral cell current frequency (carbachol, n = 8, 
control, n = 5; frequencies increased by 0.9 ! 2.4 vs. 0.1 ! 1 Hz, P = 
0.06, U-test; Fig. 5B). On the other hand, the carbachol’s action was not 
significantly reduced by a mixture of glutamatergic blockers (5 mM 
kynurenic acid, 30 !M CNQX, 50 !M D-AP5, and 500 !M MCPG, n = 8, 
vehicle, n = 6; direct bath application of 300 !M carbachol in both groups, 
frequencies increased by -0.1 ! 0.6 vs. 0.3 ! 1.2 Hz, P = 0.83, U-test; 
Fig. 5B). Although the blockers possibly reduced the carbachol effect, 
apparent mIPSC frequency increases were observed in some cells in the 
presence of the glutamatergic blockers ( Fig. 5B). 
We considered a role of mitral cells because their 
depolarization to +30 mV increased the mIPSC frequency (Fig. 5C, left), 
and application of glutamic acid, the transmitter of mitral cell, also 
increased the current frequency (Fig. 5D). However, in the presence of the 
mixed glutamatergic blockers, neither the +30 mV mitral cell depolarization 
(in the presence of 5 mM kynurenic acid + 200 !M AP3 + 50 !M CNQX + 
50 !M D-AP5, n = 5, Fig. 5C right);) nor the 100 !M glutamic acid 
application (in the presence of 5 mM kynurenic acid, 30 !M CNQX, 50 !M 
D-AP5, and 500 !M MCPG, n = 3) increased the mIPSC frequency. These 
suggest that mitral to granule cell transmission was successfully blocked by 
the mixed glutamatergic blockers. Furthermore, loading of recorded mitral 
cells with intracellular BAPTA to block the cell’s glutamate release failed 
to inhibit the effects of 100 !M carbachol (intracellular 2.5 ~ 5 mM 
BAPTA, n = 3, frequency increased by 1.9 ! 0.8 Hz). However, 
glutamate released by other mitral cells may stimulate granule cells.  
These results suggest that the carbachol directly acts on 
granule cells to stimulate their GABA release. Possibly, as reported in the 
olfactory bulb (Ghatpande et al., 2009), carbachol acts on mitral cells to 
stimulate their glutamate release, which then stimulate GABA release by 
granule cells. A role of periglomerular cells (another GABA neuron in 
AOB) was not ruled out but is less likely because cholinergic fibres are not 
seen in the periglomerular layer (Carson and Burd, 1980).   
 
Blockade of L or T-type calcium channels or intracellular 
calcium release did not reduce the carbachol’s action on the 
mIPSC frequency 
We tested the hypothesis that the carbachol action increased calcium 
channel activity in granule cells, thereby increasing calcium influx and 
GABA release. The involved calcium channel could be directly coupled, or 
not, to vesicular release. Uncoupled calcium channels can increase the 
vesicle release probability by increasing the calcium concentration in the 
release terminal. Directly coupled channels cannot be tested because, if a 
blocker is applied, the spontaneous mIPSCs will disappear. We therefore 
sought to inhibit calcium channels that are unlikely to be directly coupled to 
vesicle release.  
The L-type calcium channel blocker nifedipine, and the T-type 
blocker amiloride, or nickel chloride (100 !M) all failed to significantly 
reduce carbachol’s action (30 !M nifedipine, n = 10, vehicle, n = 8; P = 
0.29; 500 !M amiloride, n = 4, vehicle n = 4; P = 0.75; 100 !M Ni, n = 
12, control, n = 5; P = 0.84, U-test; see Supplement for details). On the 
other hand, carbachol significantly increased the current frequency in the 
presence of 20 !M mibefradil, a T-type blocker (direct bath application of 
300 !M carbachol, n = 4, vehicle only application, n = 3; frequencies 
increased by 0.2 ! 0.4 vs. -0.8 ! 1.2 Hz, P = 0.02, U-test).  
In quest of the calcium source that enhanced the spontaneous 
GABA release, we also tried blockade of intracellular calcium release. At 
15 !M, 2-APB blocks inositol 1,4,5-trisphosphate (IP3) receptor-mediated 
calcium release from endoplasmic reticulum calcium stores (Maruyama et 
al., 1997). However, no significant differences in the carbachol effect were 
shown in the presence of 2-APB at 15, 75 or 150 !M (>20 min) compared 
with its vehicle (15 !M 2-APB, n = 7, vehicle ethanol only, n = 4; 1 mM 
carbachol application in both wings, frequencies increased by 0.7 ! 1.7 vs. 
-0.3 ! 1.5 Hz, P = 0.10, U-test: see also results for 75 or 150 !M 2-APB 
in Supplement). 
However, the mIPSCs were abolished almost totally by 5 mM 
nickel chloride (n = 6; Fig. 6C) even when the mIPSC frequency was 
enhanced by carbachol. This suggests that extracellular calcium via calcium 
channels other than L or T-type are necessary for generation of the mIPSCs 
and of the increased currents resulting from carbachol administrations.  
To ascertain the source of calcium responsible for spontaneous 
GABA release, blockers of cell calcium entry were investigated (See also 
Supplement). The mitral cell currents were almost completely abolished by 
nickel chloride at 200 !M, while cadmium or cobalt at the same 
concentration was not effective (Fig. 6B, C). This suggests the involvement 
of R or T-type calcium channels, which are sensitive to nickel (Foehring et 
al., 2000). The L and T-type blockers, nifedipine (30 !M, n = 6) or 
nimodipine (30 !M, n = 5; Fig. 6B, C) were not inhibitory upon the 
mIPSCs. This implicate the R-type over the T-type calcium channel 
because the R-type channel current is not responsive to block by 
nimodipine, while the T-type current is responsive (Randall and Tsien, 
1997). Furthermore, the highly selective T-type calcium channel blocker, 
(-)-(R) enantiomer efonidipine (at saturating concentration, above 10 !M, n 
= 6; Fig. 6B, C; Perez-Reyes et al., 2009; Furukawa et al., 2004) failed to 
show any notable effect. Mixture of the P/Q-type calcium channel 
antagonist, the peptide omega-agatoxin IVA (1 !M), and the N-type 
inhibitory peptide omega-conotoxin GVIA (1 !M) had no notable influence 
upon the mIPSCs (Fig. 6B). Our findings thus implicate the role for R-type 
calcium channels in the generation of mIPSCs. 
 
KCNQ channel antagonists increased the frequency of 
spontaneous mIPSCs, while KCNQ channel openers inhibited 
the increase of mIPSC frequency by carbachol 
The KCNQ (Kv7) channel is a potassium channel that is closed by 
muscarinic action (Delmas and Brown, 2005). The potassium current 
mediated via these channels is referred to as an M-current (from 
muscarinic). Potassium channel closure excites the neurone by depolarizing 
its membrane as well as by making the membrane more susceptible to 
depolarizing inputs. Barium (1 mM), which blocks KCNQ channels 
(Constanti et al., 1981), was bath applied and resulted in a marked increase 
in mIPSC frequency (n = 10, Fig. 7A). Barium does enter through calcium 
channels, but compared with calcium, has negligible actions to release 
vesicles (Miledi, 1966). The marked effect of barium was also observed in 
the presence of a mixture of glutamatergic receptor inhibitors (5 mM 
kynurenic acid, 30 !M CNQX, 50 !M D-AP5, and 500 !M MCPG; n = 3), 
which should inhibit all of the glutamatergic receptors that are known to 
stimulate GABA release from granule cells (Castro et al., 2007). 
Furthermore, XE-991, a derivate of linodipine and a more potent and 
specific antagonist for the KCNQ channel (Elmedyb et al., 2007), increased 
the mIPSCs in the presence of the glutamatergic blockers (5 mM kynurenic 
acid, 30 !M CNQX, 50 !M D-AP5, and 500 !M MCPG in perfusate; from 
10 to 50 !M XE-991, 7 out of 9 cells; Fig. 7A). This suggests that XE-991 
closed the KCNQ channels on granule cells, depolarizing their membranes, 
and that the glutamatergic drive from mitral cells was then unnecessary for 
the increase in current frequency.     
Retigabine (80 !M), a KCNQ channel opener (expected to 
paralyse closure) inhibited the carbachol action (retigabine, n = 6, vehicle 
only, n = 5; frequencies increased by -0.1 ! 0.3 vs. 1.6 ! 2 Hz, P = 
0.03, U-test; Fig. 7B). This concentration of retigabine was expected not to 
show an observable effect on calcium channels (Rundfeldt and Netzer, 
2000) and is in the range that sufficiently blocks epileptic activity in 
hippocampus slices (Dost and Rundfeldt, 2000). Retigabine possibly 
enhances GABA receptor sensitivity (Otto et al., 2002) and inhibits the 
excitability of granule cells. However, in agreement with the retigabine 
results, another KCNQ channel opener, diclofenac (Peretz et al., 2005) also 
blocked carbachol’s action (300 !M diclofenac, n = 10, vehicle ethanol 
only, n = 6; frequencies increased by 0.1 ! 0.5 vs. 0.7 ! 1 Hz, P = 0.02, 
 4 
U-test; Fig. 7B). These consistent results suggest that both agents worked 
specifically via the opening of KCNQ channels.  
KCNQ channel opening in neurones hyperpolarizes their 
membrane potential by 10 mV (Otto et al., 2002). To rule out the possibility 
that hyperpolarization per se blocked carbachol’s action, we used low 
potassium (1.13 mM instead of 2.5 mM standard) external solution. The 
potassium equilibrium potential should be 20 mV lower (58 log 2.5/ [Kin] - 
58 log 1.13/ [Kin] = 20), thus granule cell will be hyperpolarized to this 
extent with the low-potassium solution. However, the influence of 
carbachol was apparent even under these conditions (n = 4, frequency 
increased by 0.5 ± 0.6 Hz; Fig. 7B). 
Taken together, these results suggest that KCNQ openers, by 
their specific effect, inhibited carbachol’s actions. And thus suggests 
carbachol’s action is mediated by closing KCNQ channels. 
 
Analysis of the mIPSCs suggested that they are constructed by 
synchronized multiple quantum currents  
The shapes of the mIPSCs varied greatly. Some had multiple small 
inward-current peaks, like a saw, while others had a notch when 
up-shooting to the peak (Fig.8A). These shapes suggest that a summation of 
smaller events underlie the observed currents. Current amplitude or area 
occurrence frequency histograms occasionally showed evenly spaced 
multiple peaks and dips (Fig.8B). Using Asertine analysis (Fig.8C), these 
were judged to be quantally distributed. An explanation for this is that 
synchronized multiple small quantum currents were constructing greater 
currents. 
 These results suggest that dendrodendritic synapses in the AOB 
were not saturated by a single vesicle and can accommodate multiple levels 
of transmission. This is in contrast to findings in other areas of the CNS 
cortex (Silver et al., 2003). 
 
 
Discussion 
A role for the KCNQ channel in the enhancement of the mIPSC 
by carbachol administration 
An increase in the mIPSCs by barium or XE-991 suggested that KCNQ 
channel was indeed operating at the synapse. As these actions were 
observed under the glutamatergic inhibitors, the granule cell is the likely 
site of action. Inhibition of carbachol’s action by the KCNQ channel 
openers retigabine or diclofenac suggested that carbachol acts via the 
down-regulation of KCNQ channels. The down-regulation of KCNQ 
channels increases transmitter release (Lechner et al., 2003; Martire et al., 
2004; Peretz et al., 2007; Zhang et al., 2009), and the link between 
muscarinic stimulation and KCNQ channel down-regulation is 
well-established (Delmas and Brown, 2005). It is therefore probable that 
carbachol down-regulates the activity of KCNQ channels in the granule 
cells and, through increased membrane depolarization, increases the open 
probability of membrane calcium channels, resulting in an increase in 
synaptic vesicle release.  
We examined the role of T-type calcium channels, which open 
at relatively weak depolarization levels compared with other subtypes. In 
the presence of mibefradil, however, the carbachol effect persisted, ruling 
out the T-type as the sole calcium channel involved in the enhancement of 
mIPSCs. The granule cell depolarization thus probably activates a mixture 
of calcium channel subtypes. The R-type channel is especially implicated, 
as the pharmacological profile (Fig. 6B, C) suggests a dominant role for this 
channel in the current and as the R-type channel activates at relatively low 
depolarization threshold (Soong et al., 1993) compared with other subtypes 
of high-voltage activated channels.  
In this study, actions of carbachol on mitral cell excitability were 
not studied. Thus, additional possibility that mIPSC was enhanced through 
mitral cell excitation still remains. 
 
Differences between the AOB and the olfactory bulb (OB)  
Our findings in the AOB are different from previous work in the OB, where 
the carbachol–induced increase in spontaneous GABA currents was blocked 
by the intracellular calcium store blocker thapsigargin, suggesting that 
calcium released from internal stores stimulated GABA release (Ghatpande 
et al., 2006). In contrast, in the AOB, the intracellular calcium store blocker 
2-APB did not inhibit the carbachol effect; instead, a different mechanism, 
the closure of KCNQ channels by M1 stimulation, was implicated. The 
difference in these studies possibly resulted from the ages of the animals. 
Ghatpande et al. used young rats (within 3 w), while we used mice older 
than 3 w. The expression of KCNQ3, a component of the neuronal KCNQ 
channel, continues to increase in the brain as the animal matures (Tinel et 
al., 1998). It is thus possible that the KCNQ pathway replaces the 
intracellular calcium pathway as the animal matures. Our result in the AOB 
was is in agreement with findings that the M1 ACh receptor is not linked to 
intracellular calcium stores in sympathetic neurones (Delmas and Brown, 
2002). The AOB was also less sensitive to carbachol than the OB (50 !M 
is sufficient for 300 !m slice in mouse OB; Castillo et al., 1999), and we 
had to use carbachol concentrations higher than 100 !M to see a reliable 
effect. This possibly results from fewer cholinergic fibres observed in the 
AOB external plexiform layer (site of the dendrodendritic synapses) 
compared with the OB (Carson and Burd, 1980; Ojima et al., 1988), or 
different G protein use downstream of M1 stimulation (Gudermann et al., 
1997). These disparate findings constitute another line of evidence that the 
AOB and OB are significantly different and are worth investigating 
separately. 
 
Acetylcholine may facilitate pheromonal memory formation 
The AOB dendrodendritic synapse is implicated in the plasticity of 
pheromonal memory (Brennan and Keverne, 1989; Kaba et al., 1994; 
Matsuoka et al., 2004). Female mice learn to give up responding to a mated 
male’s pheromone at a critical period just after the mating and thereafter 
become insensitive to the pheromone (Leinders-Zufall et al., 2004). 
Noradrenaline released during mating has been proposed to facilitate this 
learning (Rosser and Keverne, 1985; Kaba and Keverne, 1988; Keverne and 
Riva, 1982). However, the learning is also possible in 
noradrenaline-deficient mice (Thomas and Palmiter, 1997). This implies the 
existence of alternative candidates for the facilitation of the learning. The 
carbachol effect in our study was similar to the actions of noradrenaline in 
the AOB (Araneda and Firestein, 2006). It is possible that acetylcholine and 
noradrenaline cooperate to facilitate learning in the AOB, as they do in the 
visual cortex (Kasamatsu, 1991). 
  
A hypothesis of how increases in the spontaneous release of 
GABA facilitate synaptic plasticity 
Given that GABA is widely accepted as the major inhibitory transmitter, it 
is understandable that one could be puzzled in how increases in GABAergic 
activity, which increase inhibition, could play a permissive role in plasticity. 
However, as long as we are uncertain about the exact local membrane 
potentials and chloride concentration in the mitral cell dendrites, we cannot 
determine whether the inputs from the granule cells are actually inhibitory, 
for with lower membrane potential below the chloride equilibrium potential 
(58 log [Clex]/ [Clin]) or with higher intracellular chloride, the action of 
GABA is excitatory (Szabadics et al., 2006).  
 Assuming GABA to be inhibitory, we consider two 
possibilities to explain its role in promoting plasticity. The first possibility 
is that the inhibition by mIPSCs optimizes the sensory input by avoiding 
saturation and promising fidelity, so that the properly-transmitted 
high-frequency inputs are able to induce plasticity. The second possibility is 
that the facilitation of the spontaneous GABA release depletes the 
ready-releasable pool of GABA, and thus may desensitize granule cell 
dendrites from secreting GABA in response to trains of action potentials in 
the mitral cell dendrite,  thus releasing the mitral cell from GABA 
inhibition. In any case, further study is needed to determine the role of 
spontaneous GABA currents in AOB plasticity.  
In our experimental condition with chloride loaded mitral cells, 
mIPSCs may depolarize mitral cells and cause their glutamate release, 
which may facilitate the mIPSCs in a feed forward manner. On the other 
hand, mIPSCs should be more abundant in vivo without slicing. Thus our 
study could not precisely define the extent of the mIPSCs enhanced by 
acetylcholine in vivo. 
 
Conclusion 
The current study suggests that muscarinic stimulation, through the 
down-regulation of KCNQ channel activity, increases spontaneous GABA 
release from granule cells. This mechanism could play a role in pheromone 
memory formation. In a broader sense the AOB, because it has a simple 
structure, is a CNS region that may facilitate the study of memory. Since 
acetylcholine in the CNS is associated with memory disorders such as 
Alzheimer’s disease, and the KCNQ channel in the CNS is associated with 
epileptic disorders such as benign familial neonatal convulsions (Biervert et 
al., 1998), understanding the precise mechanism underlying the synaptic 
plasticity evident in our system may greatly increase both the understanding 
of, and the therapeutic options for, these debilitating diseases. 
 
 
Experimental procedures 
Ethical approval 
All experiments were carried out in accordance with the Kochi Medical 
School guidelines for care and use of laboratory animals. All efforts were 
made to minimize animal suffering and to reduce the number of animals 
used.  
 
Slice preparation 
Adult BALB/c mice (3 weeks to 3 months old) were sacrificed by cervical 
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dislocation. Parasagittal AOB slices (275 !m thick) were made with a linear 
tissue slicer (Pro7 Dosaka Japan) in ice-cold sucrose-replaced low calcium 
saline (sucrose 220 mM replacing NaCl, CaCl2 reduced to 0.25 mM of 
external solution, see below). The slices were incubated in a holding 
chamber, gently bubbled with an O2 (95%) and CO2 (5%) gas mixture for at 
least 40 min at room temperature. 
 
Whole cell electrophysiological recording 
Methods for whole cell patch recording are similar as described elsewhere 
(Takahashi, 1990). Briefly, slices in a recording chamber (3 ml volume) 
were continuously perfused (2 ml/min during recordings) using a peristaltic 
pump (Gilson MINIPULS3, Middleton, USA). In later experiments, a 
gravity drip system with a slower perfusion rate was used. The perfused 
Ringer’s solution consisted of (in mM): 119 NaCl, 2.5 KCl, 2.5 CaCl2, 1.3 
MgSO4, 1 NaH2PO4, 26.2 NaHCO3, and 11 glucose. The pH was 
maintained at 7.4 by saturation of the external solution with an O2 (95%) 
and CO2 (5%) gas mixture at 300 Osm. In most experiments unless noted 
otherwise, 10 mM tetra-ethyl ammonium (TEA) and 1 !M tetrodotoxin 
(TTX) were added to the external solution (“standard external solution”). 
Recordings were performed at room temperature. In winter, experiments 
were heat controlled to 26°C. Slices were viewed under an upright 
microscope (DM-LFS Leica, Wetzlar, Germany) and a CCD camera 
(C2400; Hamamatsu Photonics, Hamamatsu, Japan) using a 40" water 
immersion lens. Mitral cells were identified on the basis of their size (long 
axis greater than 20 !m), polygonal morphology, and their location in the 
middle and deep external plexiform layers. Patch pipettes with resistances 
of 2 to 8 M# were made from borosilicate glass capillaries (1B150F-4; 
WPI, Sarasota, FL, USA) using an electrode puller (P-97; Sutter 
Instruments, Novato, CA, USA) and then heat-polished. Pipettes were filled 
with an internal solution of (in mM): 140 CsCI, 10 HEPES, 5 EGTA, 3 
ATP-Mg, and 0.5 GTP-Na (pH 7.4). Membrane currents were recorded in 
the whole-cell configuration (holding potential= -70 mV). Whole cell 
current measurements were made using a patch-clamp amplifier (EPC9; 
Heka, Lambrecht, Germany). The sampling frequencies were 100 Hz (in 
most experiments) or 1 kHz (to study current trace morphology). The 
filtering frequency was 3 kHz and Rseries was not compensated. Data 
sampling and analysis were performed on a personal computer using Pulse 
(Heka), PowerLab/4SP (AD Instruments, Australia), Mini Analysis 
(Synaptosoft), Excel (Microsoft) and StatView (SAS institute, Cary, USA).  
 
Chemicals  
If not otherwise noted, chemicals were dissolved in water or, if hydrophobic, 
in dimethyl sulfoxide (DMSO) at the highest concentration according to the 
supplier’s data sheet, and stored in a -20°C freezer. Chemicals (stock 
concentration, vehicle, and storage temperature in parenthesis) were 
purchased from the following sources: Sigma (St. Louis, USA), carbachol 
(1 M or 100 mM in water, 4°C prepared daily), ATP-Mg (30 mM in water, 
4°C, prepared daily), kynurenic acid (added directly to solution, sonicated), 
TEA-Cl (1 M in water, 4°C), amiloride (directly into solution, sonicated), 
DL-2-Amino-3-phosphonopropionic acid (AP3; 100 mM in 1 N NaOHaq), 
scopolamine (100 mM in water), bicuculline methiodide (10 mM in water, 
4°C), nifedipine (30 mM in ethanol), 
1,2-bis-(2-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid (BAPTA; 25 
mM, 50 mM CsOHaq), D-2-amino-5-phosphonovaleric acid (D-AP5; 50 
mM), mibefradil, himbacine (5 mM in ethanol), 
6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX; 50 mM in DMSO), XE-991 
(100 mM in DMSO), glutamic acid (10 mM, 4°C), GABA (1 mM, 4°C), 
4-Diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP); Nakarai 
(Kyoto, Japan), TTX (100 !M in water), GTP Na (5 mM in water, 4°C, 
prepared daily), pilocarpine (50 mM in DMSO); Toronto Research 
Chemicals (North York, Canada), retigabine hydrochloride (100 or 50 mM 
in water, -20°C); Wako (Osaka, Japan), D-AP5, diclofenac (100 mM in 
ethanol); Tocris (Bristol, UK), D-AP5 (5 mM in water, 4°C), 
(RS)-!-methyl-4-carboxyphenylglycine (MCPG; 50 mM in 0.1N NaOH);  
Peptide Institute (Osaka, Japan): omega-conotoxin-GVIA (0.5 mM), 
omega-agatoxin-IVA (0.1 mM). 2-aminoethoxydiphenylborane (2APB; 10 
mM in ethanol or 100 mM in DMSO, -20°C) was kindly provided by Dr. 
Mikoshiba (Brain Science Institute, RIKEN, Japan). Efonidipine and its 
enantiomers were kindly provided by Nissan Chemical Industries, Ltd 
(Tokyo, Japan). 
For the preparation of carbachol for application to the chamber, 
a volume of the 1 M stock was applied to the perfusing solution (before 
entering the line tube) to create the desired concentration. The time of 
application was defined as the time at which the carbachol-containing 
solution began to perfuse the recording chamber (approximately 2 min after 
carbachol addition to the perfusing solution). With the chamber volume of 3 
ml, and a perfusion rate of 2 ml/min, the concentration in the chamber was 
estimated to be around 100 !M at 1 min after the start of 200!M carbachol 
application. 
A slow perfusion rate (0.2 ml/min) was used for later 
experiments to minimize costly reagent use. In these experiments, carbachol 
was directly applied into the chamber by a pipette. They are noted as ‘direct 
bath application of carbachol’ in Results. A gravity-flow setup was used to 
maintain the slow perfusion rate. The bath volume was estimated to be 2.5 
ml (though it varied from 2 to 3 ml by perfusion and vacuuming conditions). 
Carbachol concentrates of 7.5 !l (100 mM in water) were mixed with 30 !l 
of the standard solution (to enhance diffusion in the bath) and gently 
bath-applied with a pipette, resulting in a bath carbachol concentration of 
300 !M. 
 
Study design and analysis   
Most experimental manipulations were assigned either randomly, by 
throwing dice, or alternating experimental versus control conditions.  
To assess changes in the mIPSC frequency, four consecutive 
time windows of three minutes each were introduced to each cell’s 
recording. These were defined as: base, 0-3 min, 3-6 min, 6-9 min. 
Carbachol application began just after the base time window. In each cell, 
frequency values (in Hz) from the 0-3, 3-6, 6-9min time windows were 
subtracted by the frequency value of base time window, which were defined 
as frequency change values. The frequency change values from the 
experimental cell groups and the control cell groups were each pooled (cell 
number [n] " 3 values for each group) and analysed by Mann-Whitney’s 
U-test (U-test) for statistical difference (P < 0.05 was considered 
significant). The values are expressed as mean ± SD.  
We assessed three time windows after the carbachol 
application to make the analysis more specific for the detection of carbachol 
effects that tended to last for a long duration. Increases in the current 
frequency can be caused by occasional transient bursts (Fig. 1Cb, upper) 
unrelated to the carbachol effects. If only one time window after carbachol 
was assessed to count the number of events, we would not be able to 
differentiate between transient spontaneous bursts unrelated to carbachol 
and a modest but long-lasting frequency increase in response to carbachol 
(Fig. 1Ca, middle). The introduction of three time windows to a cell enables 
us to confine a transient burst to one time window and get only one value of 
increased frequency out of the cell’s three values. On the other hand, we 
can reliably identify a long-lasting response that was specific to the 
carbachol action, and get three values of increased frequency out of the 
cell’s three values. Thus, the introduction of three time windows raises the 
specificity of the analysis. 
 
Puff application of GABA    
GABA (30 !M) dissolved in the perfusing solution was puff applied (2-5 
psi, 50-500 ms at 30 s intervals) via a glass pipettes which was made 
similarly to that used for whole cell recording (Picospritzer II, General 
Valve Corporation, Fairfield, NJ, USA: for electronic pulse generation; 
SEN7203, Nihonkoden, Tokyo, Japan). Because mIPSCs often contaminate 
puff current peak values, the mean values of the puff currents were assessed. 
The puff current was calculated as follows: the averaged current trace of an 
850 ms time window beginning 100 ms after the start of the puff, minus a 
baseline value consisting of the averaged current trace of an 850 ms time 
window up to 50 ms before the start of puff (thus positive values are 
obtained for the puff current, see Fig. 3Ab). For each cell, means of the puff 
current amplitudes were calculated for the base, 0-3, 3-6, and 6-9 min time 
windows (one puff at 30 s intervals resulted in 6 amplitude values per 3 min 
time window). Ratios relative to the base values were calculated for the 0-3, 
3-6, and 6-9 min time windows and these ratios were defined as amplitude 
change ratios. The amplitude change ratio values for the carbachol-exposed 
and control groups were expressed as mean ± SD.  
 
Assessment of peaks in the mIPSC amplitude distribution 
We applied a method used by Edwards et al. (1990; Asertine’s analysis) to 
diagnose the occurrence of peaks in mIPSC amplitude histograms. The 
autocorrelation function (ACF) of the amplitude histograms was calculated 
using the expression: ACF(j) = {$i H(i)H(i+j)}/($i H(i)H(i)), where H(i) is 
the height of the ith bin which is centred at the amplitude value given by i " 
bin width. The ACFs were compared with a smoothed autocorrelation 
function in which each point was replaced by a five-point rolling average. 
The two functions were superimposed, and if the ACF showed at least two 
consecutive and equally spaced peaks and dips, the amplitudes were 
diagnosed as quantally distributed. 
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Figure Legends  
FIG. 1. Carbachol increased the frequency of spontaneous mIPSCs. A, 
Spontaneous currents reversed polarity around 0 mV, the chloride 
equilibrium potential. B, Spontaneous currents were abolished within 5 min 
by bath application of the GABAA blocker, bicuculline (20 !M). Ca, 
Examples of recordings with carbachol application. Uppermost trace: 
typical response to carbachol. Middle: delayed response. Lower: a modest 
response and rundown. Cb, Examples with vehicle application. Upper: 
transient spontaneous bursts at the final part of the recording. Middle: run 
down. Lower: stable. The scale bar is for both Ca and Cb. The angled 
arrows in Ca and Cb show the times at which carbachol or placebo 
application started. Cc, An inter-event interval cumulative plots of Ca 
uppermost trace. In this cell, the frequency increases in all three 3 min time 
windows after carbachol application (3 curves are indistinguishable in the 
plot, left side curve) were significant compared with the frequency before 
carbachol (base, right side curve) by Kolmogorov-Smirnov test. The 
numbers in the parentheses are the mean frequencies of each time window.!
D, Distributions of mIPSC frequencies in 3 min time window before and in 
3 min time window (from 3 to 6 min) after carbachol or vehicle application. 
The distribution of mIPSC frequencies after carbachol application was 
skewed and was not Gaussian. E, The U-test showed a significant increase 
in mIPSC frequency in the carbachol application group compared with the 
vehicle application group. F, A giant spontaneous current (arrow) of 
unidentified origin. Such currents were seen in the presence of TTX 1 !M. 
They were rare, but were more frequently seen in thick slices (500 !m).  
 
FIG. 2. Carbachol enhanced the amplitudes of the mIPSCs in some cells. A, 
Amplitude change ratios after carbachol or vehicle applications (any time 
window’s amplitude/base time window’s amplitude); b, base time window, 
0-3, the time window from 0 to 3 min after the application, etc. B, Upper: 
pie charts summarize the observed shifts in the amplitude cumulative plot 
curves. For each cell (carbachol application, n = 10; control, n = 6), 3 
curves for the 3 time windows were analysed. A rightward shift indicates an 
increase in amplitude, while a leftward shift, a decrease. Note that the 
rightward shifts are only observed in the carbachol-applied group. Lower: 
example cell amplitude cumulative plots from each pie chart category 
(arrow) demonstrating the shifts summarized in the chart. C, Absence of 
correlations among frequency change value and amplitude change ratio. 
This implies the amplitude change is not dependent on presynaptic calcium 
availability. Values from each time window were plotted as a point (n [cell 
number] " 3 [time windows from each cell] = 63 points), Correl: coefficient 
value.   
 
FIG. 3. Carbachol did not change the mitral cell’s sensitivity to GABA. Aa, 
GABA puffs onto a recorded mitral cell evoked currents that reversed 
around 0 mV, indicating that the currents were carried by chloride. Ab, The 
puff current value was calculated from the mean values in 850 ms time 
windows before and after the puff. B, Summary of puff current amplitudes 
before (base) and after carbachol or vehicle application (0-3, 3-6, 6-9 min). 
No significant changes in amplitude were observed. The means of 
amplitudes after the applications are shown by the ratios to the base 
amplitudes. Error bars represent SDs. See Results for detailed values. C, An 
example of a cell from the carbachol-applied group. The background 
mIPSC frequency increased independently of increases in the puff current. 
Arrows indicate the times of recordings (*1, *2) which are shown below.    
 
FIG. 4. The carbachol effect was mediated by M1 receptors. A, Muscarinic 
agonist pilocarpine increased the current frequency while muscarinic 
antagonist scopolamine blocked the carbachol effect. Pirenzepine (M1 + 
M4 antagonist) blocked the carbachol effect. On the right side of the bar 
pairs are P values by U-test. Sidebars are ± 1 SD ranges. See results for 
further details. B, The carbachol effect was apparent in the presence of 
himbacine (M2 + M4 antagonist) or 4-DAMP (M3 antagonist). 
 
FIG. 5. Carbachol could increase the mIPSC frequency without effect on 
glutamate release from mitral cells. A, Schematic drawing of the 
dendrodendritic synapse in the accessory olfactory bulb. Glutamatergic and 
GABAergic synapses reside in close proximity. When a mitral cell releases 
glutamate, the granule cell depolarizes and releases GABA back onto the 
mitral cell. B, Carbachol effect remained in the presence of mixtures of 
ionotropic and metabotropic glutamatergic receptor antagonists. On the 
right side of the bar pairs are P values by U-test. Sidebars are ± 1 SD 
ranges. See results for further details. C, Cells frequently showed robust 
increases in the mIPSC frequency when the holding potential was raised 
from –70 mV to +30 mV (left). The recorded cell likely releases glutamate 
as a result of depolarization and stimulates granule cells to release GABA 
reciprocally. In the presence of mixed glutamatergic blockers, the frequency 
increase by mitral cell depolarisation was never observed (right, with 5mM 
kynurenic acid + 200 !M AP3 + 50 !M CNQX + 50 !M D-AP5). D, Bath 
application of glutamic acid (100 !M) caused a robust increase in the 
mIPSC frequency. Kynurenic acid + AP3 blocked the action (not shown). 
An arrow indicates the time of the direct bath application.  
 
FIG. 6. A, Antagonists of L- or T-type calcium channels or intracellular 
calcium had no significant effect on the carbachol’s action. B, Actions of 
calcium channel blockers on mIPSCs. Sensitivity to a low concentration of 
Ni suggests the involvement of T or R-type channels. An insensitivity to 
nimodipine and to the highly specific T-type blocker (-)-efonidipine 
excludes the involvement of T-type channels. P-, Q-, and N-type channels 
were also excluded as the calcium source for the recorded events. Straight 
arrows indicate the time of direct bath application of the drug concentrate 
by a pipette. Abbreviations: Ni, nickel chloride; Cd, cadmium chloride; Co, 
cobalt chloride; (-)Efo, R(-) enatiomer of efonidipine; Nimo, nimodipine; 
AgaIV, omega-agatoxin-IVA; ConoVI, omega-conotoxin-GVIA. C, 
Summary of the actions of calcium channel blockers (in !M) on mIPSC. 
The profile of inhibition by calcium channel blockers suggests a dominant 
role of R-type calcium channel underlying the mIPSC activity. 
  
FIG. 7. A, Barium caused a robust increase in the mIPSC frequency. This 
suggests the involvement, in the AOB, of KCNQ channels which, when 
closed by barium, allow the depolarization of granule cells. The KCNQ 
channel-specific antagonist XE-991 also increased the mIPSCs 
(glutamatergic blockers present). Barium or XE-991 increased mIPSCs 
regardless of the presence or absence of glutamate receptor antagonists.!B, 
KCNQ channel openers blocked the carbachol effect. On the right side of 
the bar pairs are P values by U-test. Sidebars are ± 1 SD ranges. See results 
for further details.  
 
FIG. 8. Synchronized multiple quantum currents compose the mIPSCs. A, 
Examples of notched currents, which indicate the summation of quanta 
currents. B, Amplitude distribution showed some peaks at regular intervals. 
C, Asertine analysis of B. The analysis reveals the amplitude peaks to be at 
regular intervals. A line represents the autocorrelation function (ACF) of 
the simulated data shown in panel A. The curve of a dotted line represents 
the ‘smoothed’ ACF, i.e. the curve created by averaging each point of the 
original ACF and the two points on either side of it. Note that the original 
ACF crosses the smoothed ACF at somewhat regular intervals. 
 
 
Supplementary Figure Legend 
FIGURE  The profile of inhibition by calcium channel blockers. Straight 
arrows indicate the time of direct bath application of the drug concentrate 
by a pipette. A modest sensitivity of the currents to high-dose T-type 
blockers, was observed probably due to their non-specific actions. 
Insensitivity to D-AP5 excluded NMDA channels as the calcium source for 
the recorded events. Abbreviations: Ami, amiloride; Mib, mibefradil; Nif, 
nifedipine; (+/-)Efo, racemic mixture of efonidipine; Nimo, nimodipine; 
AgaIV; omega-agatoxin-IVA; ConoVI, omega-conotoxin-GVIA; SNX, 
SNX-482 (tarantula spider venom peptide, R-type selective antagonist). 
 8 
Supplements 
Supplementary Results  
Unsuccessful attempts to block carbachol actions by calcium 
channel blockers 
The L-type calcium channel blocker nifedipine, and the T-type blocker 
amiloride, or nickel chloride (100 !M) all failed to significantly reduce 
carbachol’s action (30 !M nifedipine, n = 10, vehicle ethanol only, n = 8; 
1mM carbachol application in both groups, frequencies increased by 0.5 ± 
0.9 vs. 0.5 ± 1.5 Hz, P = 0.29, U-test) (500 !M amiloride, n = 4, vehicle 
only, n = 4; 1mM carbachol application in both groups frequencies 
increased by 0.2 ± 0.2 vs. 0.4 ± 0.6 Hz, P = 0.75, U-test) (100 !M Ni, n = 
12, control, n = 5; 200 !M carbachol application in both groups frequencies 
increased by 0.0 ± 0.5 vs. 0.0 ± 0.8 Hz, P = 0.84, U-test). 
Also, when the calcium channels were non-specifically 
blocked (probably partially because mIPSC activity should disappear [that 
was not the case] if calcium channels were completely blocked), by 
lowering the calcium concentration (0.1 mM) and increasing magnesium 
(3.6 mM) in the external solution, robust increases in the mIPSC frequency 
by 200 !M carbachol application were still observed (n = 12, uncontrolled, 
frequency increased by -0.1 ± 0.5 Hz).  
 
Actions of calcium channel blockers on mIPSCs (see 
Supplementary figure) 
The T-type channel blockers amiloride (1 mM) or mibefradil (30 
!M) had a modest effect, though the concentrations required for the effect 
were higher than their T-type selective range (Suppl. figure; Randall and 
Tsien, 1997; Soong et al., 1993; Viana et al., 1997). The L and T-type 
blockers, nifedipine (30 !M, n = 6) or nimodipine (30 !M, n = 5), were not 
inhibitory upon the mIPSCs while the efonidipine racemic mixture (30 !M, 
saturated, n = 4; Perez-Reyes et al., 2009; Furukawa et al., 2004) had a 
modest effect. SNX-482 (1 !M), a peptide that inhibits R-type currents in 
certain brain regions (Wilson et al., 2000), also failed to show any notable 
effect. Another possible calcium entry site, the NMDA channel, was ruled 
out using D-AP5 (50 !M), which failed to inhibit mIPSCs. 
 
Inhibition of intracellurar pathways such as PLC or inositol 
1,4,5-trisphosphate (IP3) receptors did not abolish the carbachol 
effect  
Subtype M1, M3, and M5 muscarinic receptors up-regulate 
phospholipase C (PLC) activity while M2 and M4 down-regulate adenylate 
cyclase (AC) activity (Caulfield and Birdsall, 1998). The effectiveness of 
pirenzepine upon the actions of carbachol suggests an involvement of the 
M1 receptor, which signals via PLC. We therefore studied the influence of 
PLC pathway blockade upon the carbachol effect. At 15 !M, 2-APB blocks 
IP3 receptors of the endoplasmic reticulum (ER) and IP3-mediated calcium 
release from ER stores (Maruyama et al., 1997). A higher concentration (75 
!M) also blocks some store-operated calcium channels and some TRP 
channels. No significant differences in the carbachol effect were shown in 
the presence of 2-APB at 15, 75 or 150 !M (>20 min) compared with its 
vehicle ethanol or DMSO (15 !M 2-APB, n = 7, vehicle ethanol only, n = 
4; 1 mM carbachol application in both groups, frequencies increased by 0.7 
± 1.7 vs. -0.3 ± 1.5 Hz, P = 0.10, U-test)(2-APB 75 !M, n = 10, vehicle 
DMSO only, n = 5; 200 !M carbachol application in both groups, 
frequencies increased by -0.5 ± 0.8 vs. -0.2 ± 0.4 Hz, P = 0.18, U-test) (150 
!M 2-APB, n = 9, vehicle DMSO only, n = 6; 1 mM carbachol application 
in both groups, frequencies increased by 0.0 ± 1.2 vs. -0.1 ± 0.8 Hz, P = 
0.78, U-test). Furthermore, in the presence of gadolinium (10 !M), an 
inhibitor of store-operated calcium channels and TRP channels (Trebak et 
al., 2002), carbachol had a robust effect (n = 1, frequency increased by 0.6 
± 0.4 Hz). Thus, intracellular calcium, calcium store-operated calcium 
channels, and TRP channels are not significantly involved. Application of 
the protein kinase C inhibitor, 0.5 !M calphostin (> 20 min) under normal 
fluorescent lighting condition (Bruns et al., 1991) could not abolish the 
carbachol effect (1 mM carbachol, n = 5, vehicle water only, n = 3; 
frequencies increased by 2.3 ± 1.9 vs. 0.4 ± 1.1 Hz, P = 0.005, U-test). 
In the presence of the PLC inhibitor U73122 (10 !M, >20 min), 
carbachol application significantly increased the mIPSC frequency 
compared with vehicle-only application (1 mM carbachol, n = 9, vehicle 
water only, n = 3; frequencies increased by 1.1 ± 1.1 vs. -0.3 ± 0.6 Hz, P = 
0.002, U-test).Another PLC inhibitor, 50 !M edelfosine (Horowitz et al., 
2005; Wong et al., 2007), also had no significant effect on the carbachol 
action (20 !M edelfosine, n = 8, vehicle water only, n = 8; frequencies 
increased by -0.1 ± 0.5 vs. 0.2 ± 0.7 Hz, P = 0.80, U-test) (50 !M 
edelfosine, n = 6, vehicle water only, n = 5; 200 !M carbachol application 
in both groups, frequencies increased by 1.1 ± 2.9 vs. 0.1 ± 0.3 Hz, P = 0.56, 
U-test). 
As none of the PLC pathway blockers used had any significant 
effect on the action of carbachol, we next examined the involvement of the 
adenylate cyclase (AC) pathway. In the absence of carbachol, application 
of the AC activator forskolin resulted in a robust increase in the mIPSC 
frequency (n = 4). This may result from activation of protein kinase A 
(PKA) that works to increase the size of readily releasable pools of synaptic 
vesicles by disassociating vesicles from the actin meshwork (Greengard et 
al., 1993). In the olfactory bulb, muscarinic receptors are known to 
up-regulate AC activity (Olianas and Onali, 1992; Onali and Olianas 1995). 
The AC inhibitor SQ22536, however, failed to significantly block the action 
of 100 !M carbachol (100 !M SQ22536, n = 5, vehicle water only, n = 4; 
frequencies increased by 0.2 ± 0.5 vs. 1 ± 1.3 Hz, P = 0.16, U-test). To test 
the possibility that muscarinic receptors up-regulate both AC and PLC, a 
mixture of the two antagonists, SQ22536 (300 !M) and edelfosine (50 !M), 
was added to the preparation (preincubation, 100 !M SQ22536 and 10 !M 
edelfosine for more than an hour). Under these conditions, carbachol still 
increased the mIPSC frequency significantly (direct bath application of 300 
!M carbachol, n = 4, vehicle only application, n = 4; frequencies increased 
by 1.7 ± 1.8 vs. -0.5 ± 0.5 Hz, P = 0.001, U-test). 
In the absence of carbachol, SQ22536 application (AC inhibitor), 
which had been expected to have the opposite effect of forskolin (AC 
activator), surprisingly stimulated a modest increase in the mIPSC 
frequency (5 out of 6 cells), suggesting the possibility of AC 
down-regulation being the mechanism underlying the carbachol action. 
PKA down-regulation and thus dephosphorylation may reduce KCNQ 
currents (Schroeder et al., 1998) thereby excite presynaptic membrane and 
increase GABA release. To test the possibility that muscarinic receptors 
down-regulate AC while up-regulating PLC, a mixture of 10 !M himbacine 
(blocking M2 and M4 receptors, which monopolize the AC pathway; 
Caulfield and Birdsall, 1998) and 50 !M edelfosine was used. Nonetheless, 
carbachol application significantly increased the mIPSC frequency 
compared with vehicle (direct bath application of 300 !M carbachol, n = 7, 
vehicle only application, n = 11; frequencies increased by 0.3 ± 0.8 vs. -0.6 
± 0.9 Hz, P = 0.008, U-test).  
 An alternative pathway using cyclic ADP ribose as a 
messenger (Higashida et al., 1996) was next considered. This requires long 
(> 5 h) incubation of slices with streptozotocin to deplete the NAD+ that is 
the precursor of the cyclic ADP messenger. We incubated slices with 
streptozotocin (5 mM) in addition to a PLC inhibitor (edelfosine, 10 !M for 
5 h and 50 !M for 20 min), without any noticeable effect on the action of 
carbachol (direct bath, 300 !M, data not shown). Longer incubation was not 
practical in regards to the reliability of the recordings and the health of the 
slice. 
A high concentration of carbachol stimulates Gi in addition to 
the Gq linked to M1 receptors (Gudermann et al., 1997). Gi activates 
phosphatidylinositol (PI) 3-kinase and mitogen-activated protein (MAP) 
kinase through Ras (Alberts et al., 2002). To test the possibility that 
carbachol’s action is mediated by PI3 kinase, we applied its inhibitor 
LY294002 (50 !M effective in slice; Zhang et al., 2009) combined with the 
PLC inhibitor edelfosine. Carbachol application still had apparent actions 
under these conditions (20 !M LY294002 + 10 !M edelfosine, for more 
than 30 min in the holding chamber and thereafter, 100 !M LY294002 + 50 
!M edelfosine for more than 15 min in the recording chamber, n = 9; direct 
bath 300 !M carbachol, frequencies increased by 1.1 ± 1.4 Hz) The 
carbachol effect was also apparent in the presence of 50 !M PD98059 (an 
inhibitor of MAPK pathway; the concentration reported to be effective in 
slices; Kawasaki et al., 2004, Yuill et al., 2007) combined with edelfosine 
(10 !M PD98059 + 10 !M edelfosine, for more than 50 min in the holding 
chamber and thereafter, 50 !M PD98059 + 50 !M edelfosine for more than 
15 min in the recording chamber, n = 4; direct bath 300 !M carbachol, 
frequency increased by 0.0 ± 0.7 Hz). 
 
Supplementary Discussion 
Intracellular signalling pathway downstream of muscarinic 
stimulation 
We could not find a pathway downstream of muscarinic receptor 
stimulation. There are two possible explanations: the first possibility is that 
the inhibitors used did not sufficiently block the intracellular pathways to 
show a significant effect. However, the concentrations and durations of 
incubation for the PLC or AC blockers were likely sufficient, as they are 
effective in similar slice experiments (Herold et al., 2005; Evans et al., 
2001; Woodhall et al., 2007). Though depletion of phosphatidylinositol 
4,5-bisphosphate (PIP2) by PLC is the currently acceptable mechanism of 
KCNQ channel closure (Delmas and Brown 2005), PLC blockades act only 
marginally for the M1 receptor-KCNQ channel pathway (Bofill-Cardona et 
al., 2000; Haley et al., 2000). The possibility of cyclic ADP involvement 
remains viable, since we could not implement with our slices the long 
incubation times required to deplete the cyclic ADP ribose completely 
(Higashida et al., 1996). For the second possibility, without a need of 
intracellular pathway, G-proteins may directly modify KCNQ channels 
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(Marrion, 1997). A much potent PLC inhibitor in the future may help to 
further address this question. 
 
Supplementary experimental procedures 
Chemicals  
If not otherwise noted, chemicals were dissolved in water or, if hydrophobic, 
in dimethyl sulfoxide (DMSO) at the highest concentration according to the 
supplier’s data sheet, and stored in a -20°C freezer. Chemicals (stock 
concentration, vehicle, and storage temperature in parenthesis) were 
purchased from the following sources: Biomol (Plymouth Meeting, USA), 
calphostin (0.5 mM in DMSO); Cayman (Ann Arbor, USA), PD98059 (50 
mM in DMSO); Sigma (St. Louis, USA), U73122 (dissolved initially in 
chloroform to 10 mM, divided into 100 !l aliquots, dried, and stored at 
-20°C, then resuspended at 10 or 5 mM in DMSO and stored at -20°C); 
Nakarai (Kyoto, Japan), gadolinium chloride; Wako (Osaka, Japan), 
forskolin (10 mM in ethanol), streptozotocin (500 mM in water), LY294002 
(25 mM in DMSO); Calbiochem (Plymouth Meeting, USA), SQ22536 (100 
mM in water); Tocris (Bristol, UK), edelfosine (20 mM in water), 
(RS)-!-methyl-4-carboxyphenylglycine (MCPG; 50 mM in 0.1N NaOH); 
Peptide Institute (Osaka, Japan): SNX-482 (50 !M). 
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